Table 3.
Univariate and multivariate analysis of variables affecting overall survival (pre-PSM)
| Variable | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| P value | HR | 95% CI | P value | HR | 95% CI | |
| Sex | 0.801 | 0.830 | 0.195–3.533 | |||
| Maximum tumor diameter (<3/3–5/>5 cm) | 0.002a | 3.670 | 1.630–8.264 | 0.194 | 1.837 | 0.734–4.597 |
| Number of tumors (single/multiple) | 0.052 | 2.236 | 0.992–5.043 | |||
| MVI | 0.004a | 3.837 | 1.521–9.680 | 0.363 | 1.756 | 0.522–5.912 |
| Cirrhosis | 0.058 | 4.073 | 0.956–17.356 | |||
| IHC (HBsAg, −/+) | 0.017a | 2.574 | 1.194–5.922 | 0.021a | 2.841 | 1.169–6.905 |
| C-reactive protein | 0.002a | 4.125 | 1.707–9.968 | 0.283 | 1.712 | 0.642–4.562 |
| HBV DNA level, 10 000 IU/ml | 0.186 | 1.812 | 0.752–4.371 | |||
| Ascites | 0.028 | 2.524 | 1.102–5.778 | 0.009a | 3.346 | 1.360–8.233 |
| AFP (ng/ml, ≤400/>400) | 0.009a | 2.967 | 1.317–6.686 | 0.006a | 3.331 | 1.199–7.525 |
AFP, alpha-fetoprotein; CI, confidence interval; HBV, hepatitis B virus; HR, hazard ratio; MVI, microvascular invasion.
Statistically significant.